Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 2Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Thyroid Neoplasms 6Neuroendocrine Tumors 5Urinary Bladder Neoplasms 3Thyroid Cancer, Papillary 3Sarcoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Adenocarcinoma, Follicular 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Neuroendocrine 2Brain Neoplasms 2Adrenal Gland Neoplasms 2Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymus Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1

Interventions

Nivolumab 2pembrolizumab 1olaparib 1fludarabine phosphate 1fludarabine 1Quality of Life 1Patient Reported Outcome Measures 1PM 01183 1Molecular Diagnostic Techniques 1LY2940680 1Irinotecan 1Immunotherapy 1IPI-549 1Fluorodeoxyglucose F18 1Drug Therapy 1Cyclophosphamide 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Fluorodeoxyglucose F18 × Endocrine × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡